The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 1, 2026 | Stewart Murray | Director | Grant(A) | 110K | — | $0 |
| Jan 1, 2026 | Wyzga Michael S | Director | Grant(A) | 110K | — | $0 |
| Jan 1, 2026 | de Craecker Francoise | Director | Grant(A) | 110K | — | $0 |
| Jan 1, 2026 | Bridger Gary | Director | Grant(A) | 110K | — | $0 |
| Oct 29, 2025 | Kirske David | Chief Financial Officer | Grant(A) | 1.6M | — | $0 |
| Oct 29, 2025 | Craig Adam R | Executive Chairman, Director | Grant(A) | 2.3M | — | $0 |
| Oct 29, 2025 | Volpone John | President | Grant(A) | 2.3M | — | $0 |
| Oct 23, 2025 | Craig Adam R | Executive Chairman, Director | Buy(P) | 86K | $2.90 | $250K |
| Aug 14, 2025 | Kirske David | Chief Financial Officer | Grant(A) | 193K | — | $0 |
| Aug 14, 2025 | Kirske David | Chief Financial Officer | Grant(A) | 353K | — | $0 |
| Aug 14, 2025 | Craig Adam R | Executive Chairman, Director | Grant(A) | 290K | — | $0 |
| Aug 14, 2025 | Craig Adam R | Executive Chairman, Director | Grant(A) | 529K | — | $0 |
| Aug 14, 2025 | Volpone John | President | Grant(A) | 290K | — | $0 |
| Aug 14, 2025 | Volpone John | President | Grant(A) | 529K | — | $0 |
| Aug 12, 2025 | Kirske David | Chief Financial Officer | Grant(A) | 1.1M | — | $0 |
| Aug 12, 2025 | Craig Adam R | Executive Chairman, Director | Grant(A) | 1.6M | — | $0 |
| Aug 12, 2025 | Volpone John | President | Grant(A) | 1.6M | — | $0 |
| Jun 9, 2025 | Wyzga Michael S | Director | Grant(A) | 2K | — | $0 |
| Jun 9, 2025 | McGirr David W J | Director | Grant(A) | 2K | — | $0 |
| Jun 9, 2025 | Woods Keith | Director | Grant(A) | 2K | — | $0 |
| Jun 9, 2025 | Bridger Gary | Director | Grant(A) | 2K | — | $0 |
| Jun 9, 2025 | de Craecker Francoise | Director | Grant(A) | 2K | — | $0 |
| Jun 9, 2025 | Stewart Murray | Director | Grant(A) | 2K | — | $0 |
| May 20, 2025 | Thoren Natasha Fay | Chief Legal Officer | Grant(A) | 3K | — | $0 |
| May 16, 2025 | Baldry Mark | Chief Commercial Officer | Grant(A) | 1K | $2.48 | $3K |
| Feb 12, 2025 | DiBiase Mary | Chief Operating Officer | Grant(A) | 650K | — | $0 |
| Feb 12, 2025 | Baldry Mark | Chief Commercial Officer | Grant(A) | 600K | — | $0 |
| Feb 12, 2025 | Ragan Paula | President and CEO, Director | Grant(A) | 2.3M | — | $0 |
| Feb 12, 2025 | Mostafa Adam S. | Chief Financial Officer | Grant(A) | 850K | — | $0 |
| Feb 12, 2025 | Arbet-Engels Christophe | Chief Medical Officer | Grant(A) | 850K | — | $0 |
| Jan 24, 2025 | Arbet-Engels Christophe | Chief Medical Officer | Sell(S) | 12K | $0.45 | $5K |
| Jan 24, 2025 | DiBiase Mary | Chief Operating Officer | Sell(S) | 22K | $0.45 | $10K |
| Jan 24, 2025 | Baldry Mark | Chief Commercial Officer | Sell(S) | 29K | $0.45 | $13K |
| Jan 24, 2025 | Mostafa Adam S. | Chief Financial Officer | Sell(S) | 75K | $0.45 | $34K |
| Jan 24, 2025 | Ragan Paula | President and CEO, Director | Sell(S) | 76K | $0.45 | $34K |
| Jan 23, 2025 | Arbet-Engels Christophe | Chief Medical Officer | Grant(A) | 26K | — | $0 |
| Jan 23, 2025 | DiBiase Mary | Chief Operating Officer | Grant(A) | 61K | — | $0 |
| Jan 23, 2025 | Baldry Mark | Chief Commercial Officer | Grant(A) | 75K | — | $0 |
| Jan 23, 2025 | Mostafa Adam S. | Chief Financial Officer | Grant(A) | 75K | — | $0 |
| Jan 23, 2025 | Ragan Paula | President and CEO, Director | Grant(A) | 170K | — | $0 |
| Nov 15, 2024 | Baldry Mark | Chief Commercial Officer | Buy(P) | 13K | $0.34 | $5K |
| Nov 15, 2024 | Ragan Paula | President and CEO, Director | Sell(S) | 32K | $0.39 | $12K |
| Oct 15, 2024 | Ragan Paula | President and CEO, Director | Sell(S) | 32K | $0.56 | $18K |
| Oct 7, 2024 | Taveras Arthur | Chief Scientific Officer | Sell(S) | 77K | $0.56 | $43K |
| Oct 7, 2024 | DiBiase Mary | Chief Operating Officer | Sell(S) | 68K | $0.57 | $39K |
| Oct 7, 2024 | Ragan Paula | President and CEO, Director | Sell(S) | 239K | $0.55 | $132K |
| Oct 7, 2024 | Baldry Mark | Chief Commercial Officer | Sell(S) | 11K | $0.58 | $6K |
| Oct 7, 2024 | Mostafa Adam S. | Chief Financial Officer | Sell(S) | 231K | $0.55 | $127K |
| Oct 4, 2024 | Taveras Arthur | Chief Scientific Officer | Grant(A) | 231K | — | $0 |
| Oct 4, 2024 | DiBiase Mary | Chief Operating Officer | Grant(A) | 231K | — | $0 |
| Oct 4, 2024 | Ragan Paula | President and CEO, Director | Grant(A) | 532K | — | $0 |
| Oct 4, 2024 | Baldry Mark | Chief Commercial Officer | Grant(A) | 35K | — | $0 |
| Oct 4, 2024 | Mostafa Adam S. | Chief Financial Officer | Grant(A) | 231K | — | $0 |
| Sep 9, 2024 | DiBiase Mary | Chief Operating Officer | Sell(S) | 3K | $0.66 | $2K |
| Jun 10, 2024 | Wyzga Michael S | Director | Grant(A) | 45K | — | $0 |
| Jun 10, 2024 | Lawton Alison Frances | Director | Grant(A) | 45K | — | $0 |
| Jun 10, 2024 | Woods Keith | Director | Grant(A) | 45K | — | $0 |
| Jun 10, 2024 | Bridger Gary | Director | Grant(A) | 45K | — | $0 |
| Jun 10, 2024 | Stewart Murray | Director | Grant(A) | 45K | — | $0 |
| Jun 10, 2024 | McGirr David W J | Director | Grant(A) | 45K | — | $0 |
| Jun 10, 2024 | Aliski William | Director | Grant(A) | 45K | — | $0 |
| Jun 10, 2024 | de Craecker Francoise | Director | Grant(A) | 45K | — | $0 |
| May 17, 2024 | Baldry Mark | Chief Commercial Officer | Buy(P) | 22K | $0.68 | $15K |
| Mar 11, 2024 | DiBiase Mary | Chief Operating Officer | Sell(S) | 15K | $0.88 | $14K |
| Mar 11, 2024 | Mostafa Adam S. | Chief Financial Officer | Sell(S) | 53K | $0.88 | $46K |
| Mar 11, 2024 | Ragan Paula | President and CEO, Director | Sell(S) | 50K | $0.88 | $44K |
| Mar 11, 2024 | Taveras Arthur | Chief Scientific Officer | Sell(S) | 14K | $0.88 | $13K |
| Feb 13, 2024 | Taveras Arthur | Chief Scientific Officer | Grant(A) | 428K | — | $0 |
| Feb 13, 2024 | Baldry Mark | Chief Commercial Officer | Grant(A) | 523K | — | $0 |
| Feb 13, 2024 | Ragan Paula | President and CEO, Director | Grant(A) | 1.2M | — | $0 |
| Feb 13, 2024 | DiBiase Mary | Chief Operating Officer | Grant(A) | 428K | — | $0 |
| Feb 13, 2024 | Mostafa Adam S. | Chief Financial Officer | Grant(A) | 523K | — | $0 |
| Feb 13, 2024 | Arbet-Engels Christophe | Chief Medical Officer | Grant(A) | 181K | — | $0 |
| Feb 12, 2024 | Mostafa Adam S. | Chief Financial Officer | Sell(S) | 28K | $1.01 | $28K |
| Feb 12, 2024 | Ragan Paula | President and CEO, Director | Sell(S) | 22K | $1.01 | $22K |
| Feb 12, 2024 | Taveras Arthur | Chief Scientific Officer | Sell(S) | 787 | $1.01 | $795 |
| Feb 12, 2024 | DiBiase Mary | Chief Operating Officer | Sell(S) | 4K | $1.01 | $4K |
| Nov 3, 2023 | Ragan Paula | President and CEO, Director | Sell(S) | 40K | $0.90 | $36K |
| Nov 1, 2023 | Ragan Paula | President and CEO, Director | Sell(S) | 200K | $0.73 | $146K |
| Nov 1, 2023 | Mostafa Adam S. | Chief Financial Officer | Sell(S) | 231K | $0.73 | $168K |
| Nov 1, 2023 | DiBiase Mary | Chief Operating Officer | Sell(S) | 68K | $0.73 | $49K |
| Nov 1, 2023 | Baldry Mark | Chief Commercial Officer | Sell(S) | 10K | $0.73 | $7K |
| Nov 1, 2023 | Taveras Arthur | Chief Scientific Officer | Sell(S) | 68K | $0.73 | $49K |
| Oct 31, 2023 | Mostafa Adam S. | Chief Financial Officer | Grant(A) | 231K | — | $0 |
| Oct 31, 2023 | Baldry Mark | Chief Commercial Officer | Grant(A) | 35K | — | $0 |
| Oct 31, 2023 | Taveras Arthur | Chief Scientific Officer | Grant(A) | 231K | — | $0 |
| Oct 31, 2023 | Ragan Paula | President and CEO, Director | Grant(A) | 532K | — | $0 |
| Oct 31, 2023 | DiBiase Mary | Chief Operating Officer | Grant(A) | 231K | — | $0 |
| Oct 16, 2023 | Woods Keith | Director | Grant(A) | 90K | — | $0 |
| Sep 8, 2023 | DiBiase Mary | Chief Operating Officer | Sell(S) | 3K | $1.25 | $3K |
| Aug 31, 2023 | Arbet-Engels Christophe | Chief Medical Officer | Grant(A) | 1.3M | $1.28 | $1.6M |
| Aug 18, 2023 | Wyzga Michael S | Director | Buy(P) | 25K | $1.20 | $30K |
| Aug 10, 2023 | Stewart Murray | Interim Chief Medical Officer, Director | Sell(S) | 130K | $1.06 | $138K |
| Aug 9, 2023 | Stewart Murray | Interim Chief Medical Officer, Director | Grant(A) | 270K | — | $0 |
| Jun 30, 2023 | DiBiase Mary | Chief Operating Officer | Sell(S) | 464 | $1.89 | $877 |
| Jun 30, 2023 | Mostafa Adam S. | Chief Financial Officer | Sell(S) | 3K | $1.89 | $5K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).